Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:55 PM
Ignite Modification Date: 2025-12-25 @ 2:00 PM
NCT ID: NCT02097992
Description: None
Frequency Threshold: 3
Time Frame: None
Study: NCT02097992
Study Brief: Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Single Dose Roflumilast Participants received a single dose of 500Ug of Roflumilast for one day. 0 None 0 6 0 6 View
Single Dose Placebo Participants received a single dose Placebo for one day. 0 None 0 5 0 5 View
Multi-dose Roflumiast Participants received a daily dose of 500Ug of Roflumilast for four weeks. 0 None 0 11 1 11 View
Multi-dose Placebo Participants received a daily Placebo dose for four weeks 0 None 0 11 2 11 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
increase of cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View